XML 56 R49.htm IDEA: XBRL DOCUMENT

Balance Sheet Components - Schedule of Other Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Balance Sheet Components [Abstract]
Long-term Italian research and development refundable tax credit	$ 4,884	$ 4,053
VAT receivable	6,257	5,453
Equity investments in Lighthouse Pharmaceuticals, Inc.	78	78
Total other assets	$ 11,219	$ 9,584

This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.

+ References + Details